Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 1844 News Items found The Latest Research on Why So Many Young Adults Are Getting Cancer Monday, January 5, 2026 Learn about the latest research on why more young adults are developing cancer, from investigators across MSK. Article Treatment for Head and Neck Squamous Cell Carcinoma Affected by Bacteria Inside the Tumors Friday, January 2, 2026 Learn about MSK research showing that bacteria inside head and neck tumors can make a difference in their response to immunotherapy. New Research Finds Genetic Variant in the MSI2 Gene May Prevent Certain Blood Cancers Thursday, January 1, 2026 Scientists have discovered an inherited gene variant that may reduce the risk of developing certain blood cancers. Feature MSK Offers Second Opinions for Cancer Diagnosis: 9 Things Patients Should Know Thursday, December 18, 2025 Whether you’ve been diagnosed with a rare cancer or one that’s more common, MSK doctors can provide a second opinion. Q&A What To Know About Prostate Removal Surgery, Side Effects, and Recovery Thursday, December 18, 2025 Prostate cancer expert Jonathan Fainberg, MD, discusses the risk of complications from prostate cancer surgery and explains why not all procedures are alike. MSK Research Highlights, December 16, 2025 Tuesday, December 16, 2025 New MSK research finds a way to package protein-degrading drugs called PROTACs into nanoparticles that target blood vessels within solid tumors; identifies genomic markers that predict whether precancerous blood conditions will turn into multiple myeloma; develops a data-driven approach that could catch lymphedema earlier; and shows that nurse-led palliative care delivered by phone could serve as a scalable model. MSK Researchers Solve a Key Colorectal Cancer Mystery Monday, December 15, 2025 A new MSK study finds that in colorectal cancer, not all regulatory T cells are created equal. One subtype suppresses cancer growth while another aids it. The findings could help improve immunotherapy treatment for the majority of patients with colorectal cancer, and potentially for other cancers. MSK-Led Research Resulted in New FDA Approvals for Cancer Drugs in 2025 Monday, December 15, 2025 Learn about the clinical trials and research at MSK that led to FDA approvals in 2025, expanding treatment options for a range of different cancers. Top Cancer Research Advances at MSK in 2025 Monday, December 15, 2025 MSK researchers continued to make strides against cancer in 2025. Learn about some of their top discoveries. Top Cancer Treatment Advances at MSK in 2025 Monday, December 15, 2025 Learn about some of the most important advances in cancer treatment at MSK in 2025. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment